We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Lactate Analyzer with POC Hematocrit Compensation Launched

By LabMedica International staff writers
Posted on 10 Dec 2013
A lactate analyzer, originally developed for coaches and sportsmen, has additional features that make it suitable for further medical applications. More...


Launched by EKF Diagnostics (Cardiff, United Kingdom), the upgraded Lactate Scout+ includes built-in hematocrit compensation. This makes it suitable for a range of medical applications including cord blood lactate (CBL) analysis that can give a picture of acid-base balance at birth and is particularly recommended after high risk deliveries, fetal scalp lactate (FSL), that can be used to confirm abnormal cardiotocography values and helps to determine the need for immediate intervention in complicated births where there may be risk of insufficient fetal oxygen supply.

The in-built compensation for hematocrit (Hct) within Lactate Scout+ ensures accurate lactate measurements even at high (>50%) or low (<35%) Hct levels. The new analyzer’s Hct range is 20%–70%, which means patients with either very low Hct levels (e.g., after blood loss) or very high levels (e.g., professional athletes and neonates) can be accurately assessed. This makes Lactate Scout+ ideal for a range of medical applications. These include cardio training, weight reduction, and fitness applications which are already well established, as well as new applications in obstetrics.

EKF CEO, Julian Baines commented, “The launch of the new version of Lactate Scout+ reaffirms EKF Diagnostics’ long term expertise in lactate measurement.”

Related Links:

EKF Diagnostics



New
Gold Member
Automated MALDI-TOF MS System
EXS 3000
Collection and Transport System
PurSafe Plus®
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: The enhanced collaboration builds upon the successful launch of the AmplideX Nanopore Carrier Plus Kit in March 2025 (Photo courtesy of Bio-Techne)

Bio-Techne and Oxford Nanopore to Accelerate Development of Genetics Portfolio

Bio-Techne Corporation (Minneapolis, MN, USA) has expanded its agreement with Oxford Nanopore Technologies (Oxford, UK) to broaden Bio-Techne's ability to develop a portfolio of genetic products on Oxford... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.